2022 annual financial data
Gain Therapeutics 2022 Net margin
Direct answer
Net margin was -12,555.13%.
Operating income was -17,777,045 USD and net income was -17,590,738 USD.
Operating cash flow was -14,692,139 USD.
Get free Gain Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 140,108 USD
- Operating income
- -17,777,045 USD
- Net income
- -17,590,738 USD
- Operating cash flow
- -14,692,139 USD